Ensign Peak Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$481M Sell
1,965,769
-160,240
-8% -$37.3M 0.9% 15
2025
Q4
$440M Sell
2,126,009
-352,322
-14% -$69.7M 0.78% 19
2025
Q3
$460M Sell
2,478,331
-57,661
-2% -$9.88M 0.75% 20
2025
Q2
$387M Buy
2,535,992
+59,609
+2% +$9.16M 0.66% 23
2025
Q1
$411M Buy
2,476,383
+708,364
+40% +$111M 0.79% 21
2024
Q4
$256M Sell
1,768,019
-56,209
-3% -$8.71M 0.45% 45
2024
Q3
$296M Sell
1,824,228
-29,840
-2% -$4.75M 0.52% 35
2024
Q2
$271M Sell
1,854,068
-118,455
-6% -$17.6M 0.5% 38
2024
Q1
$312M Sell
1,972,523
-335,258
-15% -$53.4M 0.57% 35
2023
Q4
$362M Sell
2,307,781
-782,901
-25% -$120M 0.72% 25
2023
Q3
$481M Sell
3,090,682
-892,062
-22% -$147M 1.03% 15
2023
Q2
$659M Sell
3,982,744
-421,030
-10% -$68M 1.34% 12
2023
Q1
$683M Sell
4,403,774
-130,903
-3% -$21.1M 1.48% 9
2022
Q4
$801M Sell
4,534,677
-206,882
-4% -$35.7M 1.8% 6
2022
Q3
$775M Sell
4,741,559
-20,095
-0.4% -$3.4M 1.92% 6
2022
Q2
$845M Buy
4,761,654
+472,425
+11% +$84.2M 2.01% 6
2022
Q1
$760M Buy
4,289,229
+1,095,909
+34% +$186M 1.54% 7
2021
Q4
$546M Buy
3,193,320
+490,872
+18% +$80.4M 1.04% 11
2021
Q3
$436M Sell
2,702,448
-331,270
-11% -$56.5M 0.91% 15
2021
Q2
$500M Sell
3,033,718
-156,113
-5% -$25.8M 1.01% 12
2021
Q1
$524M Sell
3,189,831
-182,290
-5% -$29.5M 1.13% 10
2020
Q4
$531M Buy
3,372,121
+242,743
+8% +$35.8M 1.2% 8
2020
Q3
$466M Sell
3,129,378
-433,648
-12% -$64.2M 1.18% 9
2020
Q2
$501M Sell
3,563,026
-800,193
-18% -$117M 1.36% 8
2020
Q1
$572M Sell
4,363,219
-64,870
-1% -$9.2M 1.92% 5
2019
Q4
$646M Buy
+4,428,089
New +$601M 1.71% 5

Other funds holding JNJ

Ensign Peak Advisors's JNJ Position: Q1 2026 in Review

Ensign Peak Advisors reduced its Johnson & Johnson (JNJ) stake by 7.5% in Q1 2026, selling an estimated $37.3M and leaving 1,965,769 shares worth $481M. The position accounts for 0.9% of the portfolio, ranked #15.

Ensign Peak Advisors first reported a position in JNJ in Q4 2019 and has held it in 26 quarters since. The position peaked at $845M in Q2 2022. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Ensign Peak Advisors held 1,965,769 shares of Johnson & Johnson worth $481M as of Q1 2026.
  • Ensign Peak Advisors sold 160,240 Johnson & Johnson shares in Q1 2026, an estimated $37.3M.
  • Johnson & Johnson made up 0.9% of Ensign Peak Advisors's portfolio in Q1 2026, its #15 holding.
  • Ensign Peak Advisors first reported a position in Johnson & Johnson in Q4 2019 and has held it in 26 quarters since.
  • Ensign Peak Advisors's Johnson & Johnson position peaked at $845M in Q2 2022.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.